Healthcare | Mergers & Acquisitions

Precipart has Agreed to a Strategic Investment from KKR

  • TM Capital, together with Oaklins Switzerland, served as a financial advisor to Precipart in connection with a strategic investment from KKR
  • Precipart, founded in 1950 by the Laubscher family, is headquartered in Switzerland and produces highly engineered precision components and assemblies for medical devices as well as aerospace and industrial markets
  • The Company supports customers from concept to serial production, with major product offerings across precision machining, micro-mechanical components, assemblies, gear systems, motion solutions, technical ceramics and advanced 3D printing
  • KKR is a leading global investment firm and is investing in Precipart through its Health Care Strategic Growth Fund, which focuses on high-growth healthcare companies

Read the full press release